Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/BASILEA-PHARMACEUTICA-AG-130199/news/Basilea-announces-US-FDA-approval-of-antibiotic-ZEVTERA-ceftobiprole-medocaril-for-three-indicat-46354731/?utm_source=whatsapp&utm_medium=social&utm_campaign=share